Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C068073 |
Am 580 |
Am 580 results in increased expression of TBL2 mRNA | increases expression | 16982809
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in decreased expression of TBL2 mRNA | decreases expression | 16934159
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TBL2 mRNA | increases expression | 20106945
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of TBL2 mRNA | increases expression | 16982809
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of TBL2 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of TBL2 mRNA] | affects reaction|increases expression | 16891777
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TBL2 mRNA | increases expression | 16891777
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 14514962 11752688 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.90 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.67 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Am 580 |
4.51 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.73 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 8697196 15668235 16354765 15340226 12621046 |
MESH:D003092 |
Colitis |
|
Am 580 |
5.38 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
10.39 | 17446233 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
10.39 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.70 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.79 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.79 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.79 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
rosiglitazone |
8.06 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.06 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.09 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
9.09 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.91 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.91 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 16120746 15340226 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
4.17 | 12083418 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.28 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.28 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
5.66 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.66 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
8.39 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
8.39 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.50 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.00 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
2.64 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.64 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
3.58 | 16827153 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.64 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11118676 11399792 11896295 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |